-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19

Benzinga·08/13/2026 21:15:35
Listen to the news
UBS analyst Patrick Wood maintains Staar Surgical (NASDAQ:STAA) with a Sell and lowers the price target from $20 to $19.